Lifeward Ltd (LFWD)

$1.14 -0.06 (-5.00%)
Market Cap 13.21M
Revenue (ttm) 25.66M
Net Income (ttm) -28.94M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -112.78%
Debt to Equity Ratio 0.00
Volume 136,500
Avg Vol 146,330
Day's Range N/A - N/A
Shares Out 11.01M
Stochastic %K 14%
Beta 0.16
Analysts Strong Sell
Price Target $8.00

Latest News on LFWD

Lifeward Names Mark Grant as New CEO

May 19, 2025, 8:30 AM EDT - 24 days ago

Lifeward Names Mark Grant as New CEO

Lifeward to Present at Sidoti Virtual Investor Conference on May 21

May 19, 2025, 6:00 AM EDT - 24 days ago

Lifeward to Present at Sidoti Virtual Investor Conference on May 21

Lifeward Ltd. (LFWD) Q1 2025 Earnings Call Transcript

May 15, 2025, 9:53 AM EDT - 4 weeks ago

Lifeward Ltd. (LFWD) Q1 2025 Earnings Call Transcript

Lifeward Ltd. Reports First Quarter 2025 Financial Results

May 15, 2025, 8:00 AM EDT - 4 weeks ago

Lifeward Ltd. Reports First Quarter 2025 Financial Results

Lifeward Completes Research Program with Israeli Human-Robot Interaction Consortium to Integrate Artificial Intelligence and Exoskeletons

May 8, 2025, 8:30 AM EDT - 5 weeks ago

Lifeward Completes Research Program with Israeli Human-Robot Interaction Consortium to Integrate Artificial Intelligence and Exoskeletons

Lifeward to Report First Quarter 2025 Financial Results on May 15, 2025

May 7, 2025, 4:30 PM EDT - 5 weeks ago

Lifeward to Report First Quarter 2025 Financial Results on May 15, 2025

First Major U.S. Commercial Health Insurer Approves Purchase of ReWalk 7 Personal Exoskeleton

Apr 29, 2025, 8:30 AM EDT - 6 weeks ago

First Major U.S. Commercial Health Insurer Approves Purchase of ReWalk 7 Personal Exoskeleton

Paralyzed Israeli Soldier Walks Again with Use of the ReWalk Personal Exoskeleton

Apr 24, 2025, 8:30 AM EDT - 7 weeks ago

Paralyzed Israeli Soldier Walks Again with Use of the ReWalk Personal Exoskeleton

Lifeward Launches Sales of the ReWalk 7 Personal Exoskeleton in U.S. Market

Apr 15, 2025, 8:15 AM EDT - 2 months ago

Lifeward Launches Sales of the ReWalk 7 Personal Exoskeleton in U.S. Market

FDA Issues Clearance for ReWalk 7 Exoskeleton

Mar 13, 2025, 9:15 AM EDT - 3 months ago

FDA Issues Clearance for ReWalk 7 Exoskeleton

Lifeward Ltd. (LFWD) Q4 2024 Earnings Call Transcript

Mar 7, 2025, 11:32 AM EST - 3 months ago

Lifeward Ltd. (LFWD) Q4 2024 Earnings Call Transcript

Lifeward Ltd. Reports Fourth Quarter and Full Year 2024 Financial Results

Mar 7, 2025, 8:00 AM EST - 3 months ago

Lifeward Ltd. Reports Fourth Quarter and Full Year 2024 Financial Results

Lifeward and CorLife Finalize Partnership to Expand Workers' Compensation Access to ReWalk Exoskeleton

Mar 6, 2025, 8:00 AM EST - 3 months ago

Lifeward and CorLife Finalize Partnership to Expand Workers' Compensation Access to ReWalk Exoskeleton

Lifeward and MYOLYN Expand Partnership to Enhance Patient Access to MyoCycle FES Cycling Therapy System for Home Use

Mar 5, 2025, 8:00 AM EST - 3 months ago

Lifeward and MYOLYN Expand Partnership to Enhance Patient Access to MyoCycle FES Cycling Therapy System for Home Use

Lifeward to Report Fourth Quarter and Fiscal Year-End 2024 Financial Results on March 7, 2025

Feb 28, 2025, 8:00 AM EST - 3 months ago

Lifeward to Report Fourth Quarter and Fiscal Year-End 2024 Financial Results on March 7, 2025

Lifeward Announces CEO Transition

Feb 19, 2025, 9:10 AM EST - 4 months ago

Lifeward Announces CEO Transition

Lifeward CEO Issues Year-End 2024 Open Letter to Shareholders and Provides 2025 Commercial and Operational Priorities

Jan 13, 2025, 8:30 AM EST - 5 months ago

Lifeward CEO Issues Year-End 2024 Open Letter to Shareholders and Provides 2025 Commercial and Operational Priorities

Lifeward Cancels Its Extraordinary General Meeting of Shareholders

Jan 13, 2025, 7:45 AM EST - 5 months ago

Lifeward Cancels Its Extraordinary General Meeting of Shareholders

Lifeward Announces Closing of $5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Jan 8, 2025, 4:15 PM EST - 5 months ago

Lifeward Announces Closing of $5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Lifeward Announces $5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Jan 7, 2025, 8:05 AM EST - 5 months ago

Lifeward Announces $5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Lifeward Announces Postponement of its Extraordinary General Meeting of Shareholders

Dec 27, 2024, 5:49 PM EST - 5 months ago

Lifeward Announces Postponement of its Extraordinary General Meeting of Shareholders

Coverage for ReWalk Personal Exoskeleton Expands as Hungary Joins the U.S. and Germany with a Policy Providing Access to Exoskeletons

Nov 19, 2024, 8:30 AM EST - 7 months ago

Coverage for ReWalk Personal Exoskeleton Expands as Hungary Joins the U.S. and Germany with a Policy Providing Access to Exoskeletons

Lifeward Ltd. (LFWD) Q3 2024 Earnings Call Transcript

Nov 12, 2024, 11:30 AM EST - 7 months ago

Lifeward Ltd. (LFWD) Q3 2024 Earnings Call Transcript

Lifeward Ltd. Reports Third Quarter 2024 Financial Results

Nov 12, 2024, 8:00 AM EST - 7 months ago

Lifeward Ltd. Reports Third Quarter 2024 Financial Results

Lifeward to Report Third Quarter Financial Results on November 12, 2024

Nov 5, 2024, 4:38 PM EST - 7 months ago

Lifeward to Report Third Quarter Financial Results on November 12, 2024

Lifeward Ltd. to Present at ThinkEquity Conference on Oct 30, 2024

Oct 24, 2024, 4:30 PM EDT - 8 months ago

Lifeward Ltd. to Present at ThinkEquity Conference on Oct 30, 2024

Lifeward Launches Direct Sales of AlterG Product Line in Germany

Sep 24, 2024, 5:00 PM EDT - 9 months ago

Lifeward Launches Direct Sales of AlterG Product Line in Germany

ReWalk Robotics Ltd. Finalizes Corporate Name Change to Lifeward Ltd.

Sep 12, 2024, 8:30 AM EDT - 9 months ago

ReWalk Robotics Ltd. Finalizes Corporate Name Change to Lifeward Ltd.

Lifeward Announces Appointment of Dr. Keith E. Tansey as Consulting Director of Clinical Research

Sep 10, 2024, 8:30 AM EDT - 9 months ago

Lifeward Announces Appointment of Dr. Keith E. Tansey as Consulting Director of Clinical Research

Lifeward's First Annual Step Challenge Donates €5,000 to German Association for People Living with Spinal Cord Injury

Sep 5, 2024, 8:30 AM EDT - 10 months ago

Lifeward's First Annual Step Challenge Donates €5,000 to German Association for People Living with Spinal Cord Injury

Lifeward to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Sep 4, 2024, 4:15 PM EDT - 10 months ago

Lifeward to Present at the H.C. Wainwright 26th Annual Global Investment Conference

ReWalk Robotics Ltd. (LFWD) Q2 2024 Earnings Call Transcript

Aug 15, 2024, 1:07 PM EDT - 10 months ago

ReWalk Robotics Ltd. (LFWD) Q2 2024 Earnings Call Transcript

Lifeward to Report Second Quarter Financial Results on August 15, 2024

Aug 8, 2024, 4:15 PM EDT - 11 months ago

Lifeward to Report Second Quarter Financial Results on August 15, 2024

Lifeward Announces Appointment of Joseph E. Turk as Incoming Chairman of its Board of Directors

Jul 2, 2024, 4:30 PM EDT - 1 year ago

Lifeward Announces Appointment of Joseph E. Turk as Incoming Chairman of its Board of Directors

Lifeward Unveils Newest Addition to Its AlterG Anti-Gravity Product Line – Introducing AlterG NEO

Jun 26, 2024, 8:30 AM EDT - 1 year ago

Lifeward Unveils Newest Addition to Its AlterG Anti-Gravity Product Line – Introducing AlterG NEO

Lifeward to Present at Sidoti Virtual Investor Conference on June 12

Jun 4, 2024, 4:30 PM EDT - 1 year ago

Lifeward to Present at Sidoti Virtual Investor Conference on June 12

ReWalk Robotics Ltd. (LFWD) Q1 2024 Earnings Call Transcript

May 15, 2024, 1:06 PM EDT - 1 year ago

ReWalk Robotics Ltd. (LFWD) Q1 2024 Earnings Call Transcript

Lifeward Reports First Quarter 2024 Financial Results

May 15, 2024, 8:00 AM EDT - 1 year ago

Lifeward Reports First Quarter 2024 Financial Results

Lifeward to Report First Quarter Financial Results on May 15, 2024

May 7, 2024, 4:30 PM EDT - 1 year ago

Lifeward to Report First Quarter Financial Results on May 15, 2024

Lifeward Announces the Appointment of Mike Swinford to its Board of Directors

Apr 19, 2024, 8:30 AM EDT - 1 year ago

Lifeward Announces the Appointment of Mike Swinford to its Board of Directors

Medicare Revises 2024 Fee Schedule to Include Payment Rate for the ReWalk Personal Exoskeleton

Apr 12, 2024, 8:30 AM EDT - 1 year ago

Medicare Revises 2024 Fee Schedule to Include Payment Rate for the ReWalk Personal Exoskeleton

Lifeward CEO Issues Open Letter to Shareholders on Progress to Finalize Exoskeleton Medicare Payment Rate

Apr 1, 2024, 4:30 PM EDT - 1 year ago

Lifeward CEO Issues Open Letter to Shareholders on Progress to Finalize Exoskeleton Medicare Payment Rate

VA STAND Act introduced in the United States Senate

Mar 22, 2024, 8:30 AM EDT - 1 year ago

VA STAND Act introduced in the United States Senate

Lifeward Announces Reverse Share Split

Mar 13, 2024, 11:45 AM EDT - 1 year ago

Lifeward Announces Reverse Share Split

ReStore Exo-Suit Publications Demonstrate Improved Walking Outcomes Versus Conventional Stroke Therapy

Mar 8, 2024, 8:30 AM EST - 1 year ago

ReStore Exo-Suit Publications Demonstrate Improved Walking Outcomes Versus Conventional Stroke Therapy

Lifeward announces the Centers for Medicare & Medicaid Services (“CMS”) is deferring its final decision on the payment rate for personal exoskeletons so that more recent claims information on the current, more advanced ReWalk Personal Exoskeleton may be c

Mar 1, 2024, 8:45 AM EST - 1 year ago

Lifeward announces the Centers for Medicare & Medicaid Services (“CMS”) is deferring its final decision on the payment rate for personal exoskeletons so that more recent claims information on the current, more advanced ReWalk Personal Exoskeleton may be c

ReWalk Robotics Ltd. (LFWD) Q4 2023 Earnings Call Transcript

Feb 27, 2024, 1:53 PM EST - 1 year ago

ReWalk Robotics Ltd. (LFWD) Q4 2023 Earnings Call Transcript

Lifeward Reports Fourth Quarter and Full Year 2023 Financial Results

Feb 27, 2024, 8:00 AM EST - 1 year ago

Lifeward Reports Fourth Quarter and Full Year 2023 Financial Results

Lifeward to Report Fourth Quarter and Fiscal Year-End 2023 Financial Results on February 27, 2024

Feb 20, 2024, 8:30 AM EST - 1 year ago

Lifeward to Report Fourth Quarter and Fiscal Year-End 2023 Financial Results on February 27, 2024

ReWalk Robotics Transforms Company Identity, Rebrands as Lifeward

Jan 29, 2024, 8:00 AM EST - 1 year ago

ReWalk Robotics Transforms Company Identity, Rebrands as Lifeward